OraSure Technologies, Inc. (NASDAQ:OSUR) CFO Kenneth J. Mcgrath Acquires 64,000 Shares

OraSure Technologies, Inc. (NASDAQ:OSUR - Get Free Report) CFO Kenneth J. Mcgrath acquired 64,000 shares of the business's stock in a transaction dated Thursday, February 27th. The stock was acquired at an average price of $3.15 per share, for a total transaction of $201,600.00. Following the purchase, the chief financial officer now directly owns 371,013 shares of the company's stock, valued at approximately $1,168,690.95. This trade represents a 20.85 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

OraSure Technologies Trading Up 2.6 %

OraSure Technologies stock traded up $0.09 during mid-day trading on Monday, hitting $3.57. The company had a trading volume of 1,153,365 shares, compared to its average volume of 959,187. The company has a market capitalization of $266.30 million, a price-to-earnings ratio of 23.80 and a beta of 0.05. OraSure Technologies, Inc. has a 12-month low of $2.68 and a 12-month high of $7.43. The company's fifty day moving average is $3.78 and its 200-day moving average is $4.00.

Analysts Set New Price Targets

Separately, StockNews.com downgraded OraSure Technologies from a "buy" rating to a "hold" rating in a research report on Saturday, February 22nd.

Remove Ads

Institutional Trading of OraSure Technologies

A number of hedge funds have recently added to or reduced their stakes in OSUR. Tower Research Capital LLC TRC increased its holdings in OraSure Technologies by 202.3% in the fourth quarter. Tower Research Capital LLC TRC now owns 7,821 shares of the medical instruments supplier's stock valued at $28,000 after buying an additional 5,234 shares in the last quarter. Causeway Capital Management LLC acquired a new stake in shares of OraSure Technologies during the 4th quarter valued at about $36,000. Raymond James Financial Inc. purchased a new position in shares of OraSure Technologies in the 4th quarter valued at about $37,000. Boothbay Fund Management LLC acquired a new position in OraSure Technologies in the 4th quarter worth about $42,000. Finally, Gotham Asset Management LLC acquired a new position in OraSure Technologies in the 4th quarter worth about $43,000. 93.50% of the stock is owned by hedge funds and other institutional investors.

About OraSure Technologies

OraSure Technologies, Inc, together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company's products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.